期刊文献+

还原性谷胱甘肽在治疗药物性肝炎的临床疗效 被引量:3

Clinical curative effect of the treatment of Glutathione therapy for drug hepatitis
在线阅读 下载PDF
导出
摘要 目的:观察还原性谷胱甘肽在治疗药物性肝炎中的临床疗效方法将我院从2009年1月至2011年12月收治的113名由药物导致的肝炎住院病患随机分为AB两组,其中A组56例为治疗组,B组57例为常规治疗组对照组,两组均在停用肝损害药物的基础上,同时进行常规保肝治疗,A组在常规保肝药物的治疗基础上加用还原性谷胱甘肽1.8g/d静点,疗程5周。结果:A、B两组患者临床症状均有显著改善,A组治疗有效率(94.6%)显著高于B组治疗有效率(75.4%),差异有统计学意义(P<0.05)。结论:还原性谷胱甘肽针对药物性肝炎的治疗较常规治疗手段具有显著的治疗作用。 Objective To evalute the clinical curative.effect of Glutathione therapy for drug hepatitis. Methods Randomly divided the 113 cases of patients of drug hepatitis during from JUN, 2009 to DEC, 2011, into 2 groups: 56 in group A, got the therapy of Glutathione ( 1. 8g/d) with routine hepatoprotection therapy , and 57 in group B got routine hepatoprotection therapy alone. The ther- apy lasted 5 weeks and then selected the date of curative effect. Results there were effective The therapy effective curative effect in both group A and B. the rates of A (94. 6% ) was higher than group B (75. 4% ) and it shown greatly difference from each other (P 〈 0. 05). Conclusion the therapy of Glutathione with routine hepatoprotection has the better therapeutic efficacy .
作者 潘志红
出处 《中国民族民间医药》 2012年第13期25-26,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 还原性谷胱甘肽 药物性肝炎 临床疗效 Glutathione drug hepatitis curative effect
  • 相关文献

参考文献5

二级参考文献24

  • 1厉有名.药物性肝损害的临床类型及诊断策略[J].中华肝脏病杂志,2004,12(7):445-446. 被引量:252
  • 2张涛,贾继东.87例药物性肝损害病因和临床表现分析[J].中国临床医生杂志,2006,34(3):29-31. 被引量:9
  • 3邢同京,陈加保,张光曙,甘天福,丁明权,阎承玉.利福平与异烟肼合用致肝损害的临床与病理分析[J].中华结核和呼吸杂志,1997,20(1):33-35. 被引量:80
  • 4王浩.抗结核药所致肝损害防治的进展[J].临床肝胆病杂志,1990,(3):125-126.
  • 5Hoofnagle JH. Drug-induced liver injury network(DILIN)[J].Hepatology, 2004,40 : 773.
  • 6Teleman MD, Chee CBE, Earnest A, et al.Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore[J]. Int Tuberc Lung Dis, 2002,6(8) : 699.
  • 7Turkatas H, Unsal M, Tulek N, et al. Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazidand and pyrazinamide ) or viral hepatitis[J]. Tuber Lung Dis, 1994, 75:325 -327.
  • 8Friedenberg F,Jensen G,Gujral N,et al.Serumalbuminispredictive of 30 daysurvival after percutaneousen doscopicgastrostomy[J].JPEN,1997,21:72-74.
  • 9Park,Williams D P,Naisbitt D J,et al.Investigation otoxicmetabo litesdufing drugdev elopment[J].Toxicologand Applied Pharmacology,2005,207 (2Suppl):S425.
  • 10Zollner G,Trauner M.Molecular pathogenesis of cholestasis[J].Wien Med Wochenschr,2006,156(13 214):380.

共引文献123

同被引文献32

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部